References
- Cerletti, A. 2005. Decision regarding LSD-25 and other hallucinogenic substances. In LSD: My problem child 1979. English Translation by Jonathan Ott, ed. A. Hofmann. 85. Santa Cruz, CA: MAPS.
- Fadiman, J. 2016. Microdose research: Without approvals, control groups, staff or funding. Psychedelic Press Journal 15:1–7.
- Fadiman, J., and S. Korb. 2019. Microdosing Psychedelics. In Advances in psychedelic medicine, ed. M. Winkleman and B. Sessa, 318–335. Santa Barbara, CA: ABC/CLIO.
- Gasser, P., K. Kirchner, and T. Passie. 2015. Lsd-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects. Journal Of Psychopharmacology 29:57–68. doi:10.1177/0269881114555249.
- Grob, C., and A. Hoffman. 2002. A conversation with Albert Hofmann. In Hallucinogens: A reader, ed. C. Grob, 17. New York, NY: Tarcher/Putnam.
- Hofmann, A. 2005. LSD: My problem child, English Translation by Jonathan Ott. 2005. Santa Cruz, CA: MAPS. (Original work published 1979)
- Knowles, R. 2018. Microdosing practices amongst indigenous peoples East and West. Paper presented at the 38th Annual Conference for The Society for the Anthropology of Consciousness, Palo Alto, CA. March 24
- Madsen, M. 2018. Psilocybin occupancy and modulation of serotonin 2A receptors: PET studies in humans. Paper presented at the 1st Colloquium on Psychedelic Psychiatry, Stockholm, October 14.
- Passie, T. 2018. The science of microdosing psychedelics. UK: PsyPress.
- Sherman, R., S. Anderson, G. Dai Pan, G. Gray, T. Gross, N. L. Hunter, L. LaVange, D. Marinac-Dabic, P. W. Marks, M. A. Robb, et al. 2016. Real-world evidence — what is it and what can it tell us? New England Journal of Medicine 375 December 8, 2016:2293–97. doi:10.1056/NEJMsb1609216